These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10698626)

  • 1. HPV oncoprotein E6 is a structure-dependent DNA-binding protein that recognizes four-way junctions.
    Ristriani T; Masson M; Nominé Y; Laurent C; Lefevre JF; Weiss E; Travé G
    J Mol Biol; 2000 Mar; 296(5):1189-203. PubMed ID: 10698626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6.
    Ristriani T; Nominé Y; Masson M; Weiss E; Travé G
    J Mol Biol; 2001 Jan; 305(4):729-39. PubMed ID: 11162088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain substructure of HPV E6 oncoprotein: biophysical characterization of the E6 C-terminal DNA-binding domain.
    Nominé Y; Charbonnier S; Ristriani T; Stier G; Masson M; Cavusoglu N; Van Dorsselaer A; Weiss E; Kieffer B; Travé G
    Biochemistry; 2003 May; 42(17):4909-17. PubMed ID: 12718532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis.
    Nominé Y; Masson M; Charbonnier S; Zanier K; Ristriani T; Deryckère F; Sibler AP; Desplancq D; Atkinson RA; Weiss E; Orfanoudakis G; Kieffer B; Travé G
    Mol Cell; 2006 Mar; 21(5):665-78. PubMed ID: 16507364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain.
    Mansur CP; Marcus B; Dalal S; Androphy EJ
    Oncogene; 1995 Feb; 10(3):457-65. PubMed ID: 7845670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modular character of a DNA junction-resolving enzyme: a zinc-binding motif in bacteriophage T4 endonuclease VII.
    Giraud-Panis MJ; Duckett DR; Lilley DM
    J Mol Biol; 1995 Oct; 252(5):596-610. PubMed ID: 7563077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fission yeast nascent polypeptide-associated complex binds to four-way DNA junctions.
    Whitby MC; Dixon J
    J Mol Biol; 2001 Mar; 306(4):703-16. PubMed ID: 11243781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk HPV E6 oncoproteins assemble into large oligomers that allow localization of endogenous species in prototypic HPV-transformed cell lines.
    García-Alai MM; Dantur KI; Smal C; Pietrasanta L; de Prat-Gay G
    Biochemistry; 2007 Jan; 46(2):341-9. PubMed ID: 17209544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6.
    Pim D; Banks L
    Oncogene; 1999 Dec; 18(52):7403-8. PubMed ID: 10602499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric ScFvs blocks the E6-mediated degradation of cellular p53.
    Giovane C; Trave G; Briones A; Lutz Y; Wasylyk B; Weiss E
    J Mol Recognit; 1999; 12(2):141-52. PubMed ID: 10398405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of well-defined soluble aggregates upon fusion to MBP is a generic property of E6 proteins from various human papillomavirus species.
    Zanier K; Nominé Y; Charbonnier S; Ruhlmann C; Schultz P; Schweizer J; Travé G
    Protein Expr Purif; 2007 Jan; 51(1):59-70. PubMed ID: 17055740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV-16 E6 oncoprotein induces mutations via p53-dependent and -independent pathways.
    Kim HJ; Guo W; Park NH
    Oncol Rep; 2000; 7(4):707-12. PubMed ID: 10854530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical co-expression of human papillomavirus type 16/18 transforming (E6) oncoprotein and p53 tumour suppressor gene proteins in oesophageal cancer.
    Agarwal SK; Chatterji A; Bhambhani S; Sharma BK
    Indian J Exp Biol; 1998 Jun; 36(6):559-63. PubMed ID: 9731468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the HPV-16 E2 transcriptional activator and p53.
    Massimi P; Pim D; Bertoli C; Bouvard V; Banks L
    Oncogene; 1999 Dec; 18(54):7748-54. PubMed ID: 10618715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus oncoprotein E6 binds to the C-terminal region of human minichromosome maintenance 7 protein.
    Kukimoto I; Aihara S; Yoshiike K; Kanda T
    Biochem Biophys Res Commun; 1998 Aug; 249(1):258-62. PubMed ID: 9705868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of HPV E6 proteins in cellular transformation.
    Huibregtse JM; Beaudenon SL
    Semin Cancer Biol; 1996 Dec; 7(6):317-26. PubMed ID: 9284524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 in complex with DNA is resistant to ubiquitin-dependent proteolysis in the presence of HPV-16 E6.
    Molinari M; Milner J
    Oncogene; 1995 May; 10(9):1849-54. PubMed ID: 7753560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure-selectivity and sequence-preference of the junction-resolving enzyme CCE1 of Saccharomyces cerevisiae.
    White MF; Lilley DM
    J Mol Biol; 1996 Mar; 257(2):330-41. PubMed ID: 8609627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E6*, the 50 amino acid product of the most abundant spliced transcript of the e6 oncoprotein in high-risk human papillomavirus, is a promiscuous folder and binder.
    Heer A; Alonso LG; de Prat-Gay G
    Biochemistry; 2011 Mar; 50(8):1376-83. PubMed ID: 21226480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV-18 E6 inhibits p53 DNA binding activity regardless of the oligomeric state of p53 or the exact p53 recognition sequence.
    Thomas M; Massimi P; Banks L
    Oncogene; 1996 Aug; 13(3):471-80. PubMed ID: 8760288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.